Ann Byrne

bit.bio, England, United Kingdom

Ann has always been passionate about translating exciting science into real-world impact. She began her scientific career as an academic researcher, focusing on molecular medicine and immunology. She worked on several pre-clinical research projects in close collaboration with clinical and industry partners. During her post-graduate research, she developed an interest in the commercial side of science which led her to complete an Internship in Research Commercialisation. Subsequently, Ann embarked on a career in University Technology Transfer, where she played a vital role in assisting researchers with safeguarding, translating, and commercialising intellectual property generated from their R&D activities. Her dedication to creating long-term impact from innovative science and technology led her to transition into Business Development. She continues to be committed to driving the commercialisation of scientific breakthroughs and creating long-term value from research.

Disclosure information not submitted.

Presentation(s):

• Panel Discussion | Functional genomics for target identification: What has been achieved, what are the current challenges and what are the future opportunities

  Tuesday, February 6, 2024
  8:30 AM – 10:00 AM EST